Edition:
United States

Aceto Corp (ACET.O)

ACET.O on Nasdaq

10.84USD
18 Sep 2017
Change (% chg)

-- (--)
Prev Close
$10.84
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
262,625
52-wk High
$22.46
52-wk Low
$10.27

Chart for

About

Aceto Corporation (Aceto) is engaged in the marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products. The Company's... (more)

Overall

Beta: 1.36
Market Cap(Mil.): $326.39
Shares Outstanding(Mil.): 30.11
Dividend: 0.06
Yield (%): 2.40

Financials

  Industry Sector
P/E (TTM): -- 31.51 16.21
EPS (TTM): -- -- --
ROI: -- 15.10 14.56
ROE: -- 16.34 13.83

BRIEF-Aceto Q4 EPS $0.06

* Aceto reports fiscal 2017 fourth quarter and full year results

Aug 24 2017

BRIEF-ACETO reports Q3 earnings per share $0.16

* Q3 earnings per share view $0.44 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

May 04 2017

BRIEF-Rising Pharmaceuticals launches Zileuton extended release tablets

* Aceto subsidiary, Rising Pharmaceuticals, launches Zileuton extended release tablets, 600 mg Source text for Eikon: Further company coverage:

Mar 31 2017

BRIEF-Aceto's unit launches Capecitabine Tablets, 150 & 500 MG

* Unit, Rising Pharmaceuticals launched Capecitabine tablets, 150 & 500 MG, AB-rated generic version of Xeloda tablets from Hoffman La Roche Source text for Eikon: Further company coverage:

Mar 28 2017

Earnings vs. Estimates